The pharmaceutical landscape is experiencing a development with the arrival of GLP-1 transdermal systems . These innovative formulations offer a possible approach to providing glucagon-like peptide-1 drugs for individuals managing the disease . Instead of daily shots , a easy-to-use patch applied